Esperion Therapeutics (ESPR) Tops Q3 EPS by 18c; Reports Cash and Cash Equivalents of $153.7M
Go back to Esperion Therapeutics (ESPR) Tops Q3 EPS by 18c; Reports Cash and Cash Equivalents of $153.7M| ESPERION THERAP (NASDAQ: ESPR) | Delayed: 3.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.16 | 52 Week High | $30.41 | |||
| Open | $3.16 | 52 Week Low | $9.40 | |||
| Day High | $3.17 | P/E | N/A | |||
| Day Low | $3.15 | EPS | $-21.87 | |||
| Volume | 5,646,804 | |||||

